Ellington Management Group’s ResMed RMD Stock Holding History

Ellington Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,608	Closed	-$352K	–	722
2019 Q3	$352K	Buy	+2,608	New	+$342K	0.06%	318

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ellington Management Group's RMD Position: Q4 2019 in Review

Ellington Management Group sold out of ResMed (RMD) in Q4 2019, closing a stake of 2,608 shares — an estimated $352K sold.

Ellington Management Group first reported a position in RMD in Q3 2019 and held it in 1 quarter. The position peaked at $352K in Q3 2019. 559 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

Ellington Management Group reported no remaining ResMed position as of Q4 2019 after selling out during the quarter.
Ellington Management Group sold 2,608 ResMed shares in Q4 2019, an estimated $352K.
Ellington Management Group first reported a position in ResMed in Q3 2019 and held it in 1 quarter.
Ellington Management Group's ResMed position peaked at $352K in Q3 2019.
559 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.